U.S. Stock News

NYSE:HUM
NYSE:HUMHealthcare

Humana Illinois Medicaid Win Adds New Layer To Growth And Valuation

Humana (NYSE:HUM) has been selected as a new awardee in Illinois' HealthChoice Medicaid managed care program. The contract introduces Humana to the Illinois Medicaid managed care market, extending its business beyond its Medicare Advantage focus. This development follows recent attention on Humana's Orlando pharmacy expansion but centers on a different part of its health plan operations. For investors tracking Humana, the new Illinois Medicaid managed care contract arrives with the stock at...
NYSE:T
NYSE:TTelecom

AT&T AI Partnerships With Derq And Wiliot Highlight Valuation Gap

AT&T (NYSE:T) has expanded its AI-focused transportation and supply chain offerings through new collaborations with Derq and Wiliot. With Derq, AT&T is supporting real-time roadway safety intelligence via the Intelligent Transportation Platform for connected infrastructure and smart mobility. With Wiliot, AT&T is working to scale AI-driven asset tracking and supply chain visibility using battery-free IoT sensors across enterprise operations. For AT&T, best known for its core connectivity...
NYSE:FCPT
NYSE:FCPTSpecialized REITs

A Look At Four Corners Property Trust (FCPT) Valuation After Landmark Veterinary Portfolio Deal And Monthly Dividend Shift

Four Corners Property Trust (FCPT) is drawing attention after agreeing to acquire up to 102 Mission Pet Health veterinary properties for up to $268.0 million, while also shifting to a monthly dividend schedule starting in the third quarter of 2026. See our latest analysis for Four Corners Property Trust. FCPT’s recent acquisitions and shift to monthly dividends come as the stock trades at US$24.98, with a year-to-date share price return of 7.49% but a 1-year total shareholder return that...
NYSE:PNR
NYSE:PNRMachinery

Has Pentair (PNR) Fallen Too Far After 29% Year-To-Date Share Price Decline?

If you are wondering whether Pentair at around US$74.58 is offering genuine value or just looks cheap on the surface, it helps to line up the recent share performance against what the fundamentals say. The stock is up 4.7% over the past week, although it is down 2.9% over the past month, down 29.3% year to date and down 24.6% over the past year, which may have changed how investors view both its potential and its risks. Recent attention around the stock has focused on how the business is...
NYSE:JLL
NYSE:JLLReal Estate

A Look At JLL (JLL) Valuation After Securing $870m Loan For Four Seasons Lake Austin

Jones Lang LaSalle (JLL) is back in focus after its Capital Markets Group arranged an $870 million senior loan for the Four Seasons Private Residences Lake Austin, a large ultra-luxury residential project in Texas. See our latest analysis for Jones Lang LaSalle. Recent moves like the Austin financing come as JLL’s share price sits at US$305.61, with a 1-day share price return of 3.71% and a 90-day share price return of 5.56%. The 1-year total shareholder return of 28.74% and 3-year total...
NYSE:WAT
NYSE:WATLife Sciences

Is Waters (WAT) Price Attractive After Recent Life Sciences Coverage And Mixed Valuation Signals

If you are looking at Waters and wondering whether the current share price reflects its underlying worth, the key question is how that price lines up with the company’s fundamentals. The stock last closed at US$371.15, with returns of 4.5% over the past month, 6.1% over the past year, and 41.0% over three years. Year to date the share price is down 2.8%, and over the past week it is marginally down 0.2%. Recent coverage around Waters has focused on its role in life sciences and analytical...
NasdaqGS:MRVL
NasdaqGS:MRVLSemiconductor

Assessing Marvell Technology (MRVL) Valuation After A Powerful AI Infrastructure Driven Share Price Surge

Recent price performance and business snapshot Marvell Technology (MRVL) has drawn attention after a sharp move in its stock, with the price up about 57% over the past month and roughly 195% over the past 3 months. The company focuses on data infrastructure semiconductor solutions, serving data centers, communications providers and other markets. Its reported annual revenue is US$8.7b, with net income of US$2.5b and a market value around US$252.7b. See our latest analysis for Marvell...
NYSE:TSN
NYSE:TSNFood

Is Tyson Foods (TSN) Using Shelf Registration And New Leaders To Quietly Redefine Its Strategy?

In recent weeks, Tyson Foods filed a universal shelf registration for Class A common stock, debt securities, warrants, purchase contracts and units, while announcing multiple leadership changes including a new CEO, president and chief operating officer to oversee its global protein businesses. These moves, alongside new product launches across brands such as Wright, Hillshire Farm, Ball Park and Tyson, highlight a company simultaneously reshaping its leadership and broadening its prepared...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

A Look At Cognizant Technology Solutions (CTSH) Valuation After Recent Share Price Weakness

Cognizant Technology Solutions (CTSH) has drawn investor attention after a period of mixed share performance. The stock has been roughly flat over the past month but has declined over the past three months and year to date. See our latest analysis for Cognizant Technology Solutions. At a share price of $52.94, Cognizant’s recent moves tell a mixed story, with a 30 day share price return of 2.44% but a year to date share price decline of 34.87% and a 1 year total shareholder return decline of...
NYSE:RJF
NYSE:RJFCapital Markets

A Look At Raymond James Financial (RJF) Valuation After New Chief Architect Appointment

Why Raymond James Financial stock is in focus Raymond James Financial (RJF) has drawn fresh attention after appointing Seth Ford as Senior Vice President, Chief Architect, a move tied to its efforts around modern platforms, AI and advanced analytics across core technology systems. See our latest analysis for Raymond James Financial. At a share price of US$151.37, Raymond James Financial has seen a 7-day share price return of 3.15%, while the year-to-date share price return is down 7.48%. The...
NYSE:BX
NYSE:BXCapital Markets

Blackstone Juggles Fund Liquidity Moves And Massive AI Infrastructure Financing

Blackstone (NYSE:BX) is weighing a private equity secondary sale of more than US$2b in fund stakes, including potential use of collateralized fund obligations (CFOs) to package and securitize exposure. The company is also helping lead a record US$35b financing partnership with Apollo and Broadcom to support next generation AI and data infrastructure. Both moves come during a tough exit market for traditional private equity deals and rising interest in capital intensive AI infrastructure...
NYSE:GKOS
NYSE:GKOSMedical Equipment

Glaukos (GKOS) Valuation Check As iDose TR Adoption Renews Growth Expectations

Glaukos (GKOS) is back in focus after fresh commentary on robust adoption of its iDose TR glaucoma therapy, a shift that is sharpening attention on how its broader ophthalmic portfolio might support long-term demand trends. See our latest analysis for Glaukos. At a share price of $126.34, Glaukos has moved sharply in recent trading, with a 1 day share price return of 3.59% and a 7 day share price return of 14.05% following enthusiasm around iDose TR. The 30 day share price return is down...
NYSE:SBH
NYSE:SBHSpecialty Retail

How Sally Beauty’s Shift to Store Optimization Over Expansion Will Impact Sally Beauty Holdings (SBH) Investors

Recent commentary on Sally Beauty Holdings highlights ongoing operational challenges, including weak same-store sales, minimal new store openings, and a focus on optimizing existing locations rather than expanding its footprint. This shift toward efficiency over growth underscores the difficulty of attracting new in-store shoppers, raising questions about the long-term role of physical retail in Sally Beauty’s model. We’ll now examine how management’s emphasis on optimizing existing stores...
NYSE:BKD
NYSE:BKDHealthcare

Is Brookdale Senior Living’s (BKD) Steady Occupancy Climb Quietly Rewriting Its Utilization Story?

Brookdale Senior Living recently reported its May 2026 operating data, showing consolidated weighted average occupancy of 82.5% and month-end occupancy of 83.5%, both higher than a year earlier. The broad-based improvement in both consolidated and same community occupancy suggests that Brookdale’s efforts to strengthen demand and utilization are gaining traction across its portfolio. We’ll now examine how this occupancy uptick, particularly the move further above the 80% threshold, reshapes...
NYSE:ORCL
NYSE:ORCLSoftware

Assessing Oracle’s Valuation as Contrasting Narratives Challenge the Outlook for ORCL

What Oracle’s latest figures mean for investors Oracle (ORCL) is back in focus after recent trading put the stock around $205.81, with returns over the past month and past 3 months contrasting with longer term performance and raising fresh questions about valuation and growth durability. See our latest analysis for Oracle. Recent trading has been choppy, with the share price falling 15.9% over the past week after a strong 26.2% 3 month share price return, while the 1 year total shareholder...
NasdaqGS:CINF
NasdaqGS:CINFInsurance

A Look At Cincinnati Financial (CINF) Valuation After Solid First Quarter 2026 Results

Event driven overview Cincinnati Financial (CINF) recently reported first quarter 2026 results, highlighting improved underwriting discipline, lower catastrophe losses, and higher investment income. This update may be an important reference point for investors watching the stock. See our latest analysis for Cincinnati Financial. The first quarter update appears to have helped sentiment, with a 7 day share price return of 3.69% and a 1 year total shareholder return of 13.97% pointing to steady...
NYSE:MCO
NYSE:MCOCapital Markets

Is Moody’s Dedicated Generative AI Push Altering The Investment Case For Moody’s (MCO)?

Earlier this month, Moody’s held a special call to outline its Generative AI strategy, highlighting new partnerships and product innovation initiatives aimed at enhancing customer insights. This focus on Generative AI signals that Moody’s is prioritizing AI-enabled analytics as a core part of its future risk-assessment offerings. Next, we’ll examine how Moody’s dedicated Generative AI strategy call could influence its investment narrative and long-term analytics positioning. Capitalize on...
NYSE:TPC
NYSE:TPCConstruction

The Bull Case For Tutor Perini (TPC) Could Change Following New High-Complexity Institutional And Tech Contracts

Tutor Perini recently reported that its subsidiaries Fisk Electric and Roy Anderson Corp secured new contracts, including a US$48 million electrical project at an advanced manufacturing and data center-related facility in Houston and a roughly US$114 million academic building at the University of Mississippi, both to be completed over the next few years. These awards add to Tutor Perini’s already large backlog and underline how its specialty and building units are winning work in...
NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

Is Adaptive Biotechnologies (ADPT) Turning clonoSEQ’s MRD Momentum Into a Durable Competitive Moat?

In late May 2026, Adaptive Biotechnologies announced that its NGS-based clonoSEQ MRD test was featured in 33 presentations, including a plenary and 14 oral sessions, at the ASCO Annual Meeting in Chicago and the EHA Congress in Stockholm, underscoring its FDA-cleared, CE-marked and Medicare-covered role in hematologic cancer care. The breadth of data across multiple myeloma, CLL, ALL and lymphomas highlights how clonoSEQ’s high-sensitivity MRD testing is increasingly embedded in real-world...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

A Look At TG Therapeutics (TGTX) Valuation After Fresh BRIUMVI Clinical And Formulation Milestones

TG Therapeutics (TGTX) is drawing attention after a cluster of BRIUMVI related updates, including positive Phase 3 ENHANCE data and new subcutaneous and post hoc efficacy results in multiple sclerosis. See our latest analysis for TG Therapeutics. The BRIUMVI news has arrived alongside strong share price momentum, with a 90 day share price return of 54.62% and a year to date share price return of 48.12%. Meanwhile, the 3 year total shareholder return of 57.82% and 5 year total shareholder...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

Crocs (CROX) Taps ESOP Shelf Offering As Analyst Upgrade Tests The Brand Durability Narrative

Crocs, Inc. recently filed a US$274.60 million shelf registration for 2,200,000 common shares tied to its employee stock ownership plan, while also drawing renewed analyst confidence in its Crocs and HEYDUDE brands. Analysts highlighted effective cost management, improving revenue trends and a more confident management tone as key reasons for reassessing the company’s longer-term prospects. We’ll now examine how Baird’s upgraded view on Crocs’ North America and HEYDUDE growth prospects...
NYSE:CB
NYSE:CBInsurance

Will Chubb’s (CB) Bigger Buyback and Higher Dividend Redefine Its Capital Return Narrative?

In recent days, Chubb Limited announced a 5.2% dividend increase, its 33rd consecutive annual raise, and approved a new US$7.50 billion share repurchase program, reinforcing its ongoing capital return plans to shareholders. This combination of higher dividends and a sizable buyback authorization highlights Chubb’s confidence in its earnings power and disciplined balance sheet management, even as loss costs and catastrophe risks remain key variables. Next, we’ll examine how Chubb’s larger...
NYSE:OFG
NYSE:OFGBanks

Assessing OFG Bancorp (OFG) Valuation After A Strong First Quarter Earnings Beat

OFG Bancorp (OFG) recently reported first quarter results that beat analyst expectations on both revenue and earnings, with revenue of US$185.8 million, 4.2% higher year on year and 4.8% above forecasts. See our latest analysis for OFG Bancorp. The stock has recently reached a 52 week high, and the 90 day share price return of 19.7% alongside a 1 year total shareholder return of 14.6% suggests momentum has been building around the latest quarterly beat and recent shareholder meeting...
NasdaqGS:AXTI
NasdaqGS:AXTISemiconductor

Assessing AXT (AXTI) Valuation As AI Data Center Demand Fuels Indium Phosphide Expansion

AXT (AXTI) is back in focus after reporting robust revenue and backlog tied to indium phosphide substrates for AI and hyperscale data centers, alongside plans to double production capacity through 2027. See our latest analysis for AXT. Despite the strong AI related backdrop, AXT’s share price has been under pressure in the near term, with the stock down 13.68% over one day and 32.66% over 30 days, though its year to date share price return of 367.54% and very large 1 year total shareholder...